Webcast

Prescient Therapeutics Investor Briefing – 21 January

January 21, 2021

Prescient Therapeutics Investor Briefing – 21 January

Prescient Therapeutics (ASX: PTX) Webcast Replay

Steven Yatomi-Clarke, CEO & MD of Prescient Therapeutics (ASX:PTX) provides an update on the company’s three new next-gen CAR-T programs and using OmniCAR’s unique features to create therapies where current generation CAR-Ts have struggled,  which inserts PTX into the forefront of global CAR-T research

Recorded on 21 January 2021 at 1pm (AEDT)

Join the next Prescient Therapeutics webcast

Speak to the Reach Markets team

FEATURED SPEAKER

STEVEN YATOMI-CLARKE

Chief Executive Officer & Managing Director - Prescient Therapeutics

Speak to the Reach Markets team



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.